Rachel Swanson
Nutrition Director @ Lifespan Medicine
Los Angeles, United States
Rachel Swanson is a Series A investor at Lifespan Medicine in Los Angeles focused on Software and Health Care. Rachel Swanson, MS, RD, LDN is a Registered Dietitian and founder of the nutrition consulting practice Diet Doctors, LLC. She counsels celebrities, C-suite executives, professional athletes and physicians as the Nutrition Director for LifeSpan Medicine. Her work focuses on developing personalized treatment plans for cardiometabolic andgastrointestinal health, weight loss, disease prevention, and optimal maternal-fetal outcomes. Rachel holds a Master of Science degree in Clinical Nutrition from NYU and completed clinical rotations at Mount Sinai Hospital in Manhattan. She is an angel investor focused on the intersection of health and technology.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Rachel Swanson invests in
Stages Rachel Swanson invests in
Countries Rachel Swanson invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 2 (50%)
- Health Care 2 (50%)
- Apps 1 (25%)
- Sports 1 (25%)
- FinTech 1 (25%)
Stage
- Series A 3 (75%)
- Venture - Series Unknown 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Levels
|
Levels develops a health and wellness platform designed to monitor metabolic fitness. The platform tracks blood glucose in real-time, enabling users to optimize their diet and exercise. The company was founded in 2019 and is a remote-first company. | $38M / Series A / Apr 20, 2022 | |
Supersapiens
|
Supersapiens is a sports technology company focused on energy management systems. They develop innovative insights around glucose data using biowearable technology, resulting in long-term positive behavior change and assisting in unlocking better performance and recovery. The company's real-time glucose visibility enables them to make informeddecisions that can improve glucose levels, metabolism, and, as a result, energy levels.Supersapiens was founded in 2019 and is based in Atlanta, Georgia. | $13.5M / Venture - Series Unknown / Apr 27, 2021 | |
Digits
|
Digits is a fintech company building tools for businesses and finance professionals by leveraging its proprietary Living Model technology. The company was founded by Wayne Chang and Jeff Seibert in 2018 and is headquartered in San Francisco, California, United States. | $10.5M / Series A / Nov 06, 2019 | |
Heal
|
At Heal, we believe improving health outcomes starts by meeting patients where they're most comfortable: at home. That’s why we provide value-based, in-home primary care to seniors on Medicare and select Medicare Advantage plans. Heal’s service model allows board-certified doctors and nurse practitioners to spend more time with their patients,so care is never rushed, and a strong patient-provider relationship is established.We serve seniors at all stages of their health journey, from preventive care -- like flu shots and annual physicals -- to treating common illnesses and managing chronic conditions. Our services also include telemedicine visits and remote health monitoring, so getting quality care when its needed is easier than ever.With easy and convenient phone support for scheduling or other questions, we offer appointments 8am-6pm, 7 days/week – including weekends and holidays. | $23M / Series A / Oct 18, 2016 |
Co-Investors
About Lifespan Medicine
Lifespan Medicine is a medical practice that offers a variety of healthcare services from comprehensive concierge programs.
Lifespan Medicine Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chris Renna
Founder
|
|||
|
Rachel Swanson
Nutrition Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Rachel Swanson invest in?
Rachel Swanson invests primarily in Software, Health Care and Apps startups, most often at Series A and Venture - Series Unknown stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Rachel Swanson?
Public channels for Rachel Swanson include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Rachel Swanson last invest?
The most recent investment recorded for Rachel Swanson closed in Apr 2022. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
